PP

Piyush Popatlal Shah

Director Director DIN 01002903
DIN 01002903 First appointment Mar 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 1999
Shareholding value •••• Premium profile

About Piyush Popatlal Shah

Data last updated:

Piyush Popatlal Shah was a Director at Omni-Protech Drugs Private Limited (1999–2011) and Director at H. M. & Company Medisales Private Limited (2011–2017). The companies operate in Pharma.

DIN 01002903
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 1999

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Omni-Protech Drugs Private Limited U24239PN1993PTC071120
Director31 Mar 19991993₹24.63 Cr (FY 2025)Active
Director20 Jun 20112011Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Omni-Protech Drugs Private Limited
H. M. & Company Medisales Private Limited
Premium access

Shareholding and investment profile for Piyush Popatlal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Piyush Popatlal Shah

Piyush Popatlal Shah was first appointed on 31 Mar 1999 as Director at Omni-Protech Drugs Private Limited. The most recent appointment on record is 20 Jun 2011 at H. M. & Company Medisales Private Limited.

Piyush Popatlal Shah held 2 earlier board appointments: Omni-Protech Drugs Private Limited (Director, 31 Mar 1999 to 31 Oct 2011); H. M. & Company Medisales Private Limited (Director, 20 Jun 2011 to 15 Dec 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available